Pathophysiology of platelet thrombin receptors

Thrombosis and Haemostasis

Volumn 78, Issue 1, 1997, Pages 242-246

  Jamieson, Graham A ^a  

^a AMERICAN RED CROSS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN IB; GUANINE NUCLEOTIDE BINDING PROTEIN; PHOSPHOLIPASE A2; PHOSPHOLIPASE C; RECEPTOR; THROMBIN; THROMBIN RECEPTOR;

CONFERENCE PAPER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE ACTIVATION;

EID: 0030843881     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1657533     Document Type: Conference Paper

References (49)

1. Jamieson GA. The activation of platelets by thrombin: A model for activation by high and moderate affinity receptor pathways. In: Jamieson GA, ed. Platelet Membrane Receptors: Molecular Biology, Immunology, Biochemistry, and Pathology. New York: Alan R. Liss, Inc., 1988:137-158.
2. Greco NJ, Jamieson GA. High and moderate affinity pathways for a-thrombin-induced platelet activation. Proc Soc Exp Biol Med 1991; 198:792-799.
3. Harmon JT, Jamieson GA. Thrombin binds to a high-affinity ∼900,000 dalton site on human platelets. Biochemistry 1985; 24:58-64.
4. De Marco L, Mazzucato M, Masotti A, Fenton JW, Ruggeri ZM. Function of glycoprotein Ib alpha in platelet activation induced by alph α-thrombin. J Biol Chem 1991; 266:23776-23783.
5. Gralnick HR, Williams S, McKeown LP, Hansmann K, Fenton JW, III, Krutzsch H. High-affinity α-thrombin binding to platelet glycoprotein Ibα: Identification of two binding domains. Proc Natl Acad Sci USA 1994; 91:6334-6338.
6. Greco NJ, Tenner Jr, T.E., Tandon NN, Jamieson GA. PPACK-thrombin inhibits thrombin-induced platelet aggregation and cytoplasmic acidification but does not inhibit platelet shape change. Blood 1990; 75:1983-1990.
7. Greco NJ, Tandon NN, Jamieson GA. Thrombin binding to platelets defines functional receptors: Inhibition of thrombin-induced platelet activation by catalytically-inactivated thrombin. Platelets 1995; 6:270-274.
8. Mazurov AV, Vinogradov DV, Vlasik TN, Repin VS, Booth WJ, Berndt MC. Characterization of an antiglycoprotein Ib monoclonal antibody that specifically inhibits platelet-thrombin interaction. Thromb Res 1991; 62:673-684.
9. i induced by α-thrombin. Biochemistry 1996; 35:906-914.
10. Peng M, Emig FA, Mao A, et al. Interaction of echicetin with a high affinity thrombin binding site on platelet glycoprotein GPIb. Thromb Haemost 1995; 74:954-957.
11. McNicol A, Sutherland M, Zou r, Drouin J. Defective thrombin-induced calcium changes and aggregation of Bernard-Soulier platelets are not associated with deficient moderate-affinity receptors. Arterioscler Thromb & Vascular Biol 1996; 16:628-632.
12. Harmon JT, Jamieson GA. Activation of platelets by alpha-thrombin is a receptor-mediated event. J Biol Chem 1986; 261:15928-15933.
13. Brower MS, Levin RI, Garry K. Human neutrophil elastase modulates platelet function by limited proteolysis of membrane glycoproteins. J Clin Invest 1985; 75:657-666.
14. 2+ responses of protease-treated human platelets activated with α-thrombin and the tethered ligand peptide. Biochemistry 1996; 35:915-921.
15. Lopez JA. The platelet glycoprotein Ib-IX complex. Blood Coagul Fibrinolysis 1994; 5:97-119.
16. Parry MAA, Stone SR, Hofsteenge J, Jackman MP. Evidence for common structural changes in thrombin induced by active-site or exosite binding. Biochem J 1993; 290:665-670.
17. Vijayalakshmi J, Padmanabhan KP, Mann KG, Tulinsky A. The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: Changes accompanying activation and exosite binding to thrombin. Protein Sci 1994; 3:2254-2271.
18. Wu Q, Sheehan JP, Tsiang M, Lentz SR, Birktoft JJ, Sadler JE. Single amino acid substitutions dissociate fibrinogen-clotting and thrombomodulin-binding activities of human thrombin. Proc Natl Acad Sci USA 1991; 88:6775-6779.
19. Okumura T, Jamieson GA. A single receptor for platelet aggregation induced by thrombin or ristocetin. Thromb Res 1976; 8:701-706.
20. De Marco L, Mazzucato M, Masotti A, Ruggeri ZM. Localization and characterization of an α-thrombin-binding site on platelet glycoprotein Ibα. J Biol Chem 1994; 269:6478-6484.
21. Ward CM, Andrews RK, Smith AI, Berndt MC. Mocarhagin, a novel cobra venom metalloproteinase, cleaves the platelet von Willebrand factor receptor glycoprotein Ibα. Identification of the sulfated tyrosine/anionic sequence Tyr-276-Glu-282 of glycoprotein Ibα as a binding site for von Willebrand factor and α-thrombin. Biochemistry 1996; 35:4929-4938.
22. Marchese P, Murata M, Mazzucato M, et al. Identification of three tyrosine residues of glycoprotein Ibα with distinct roles in von Willebrand factor and α-thrombin binding. J Biol Chem 1995; 16:9571-9578.
23. Dong J-F, Li CQ, Lopez JA. Tyrosine sulfation of the glycoprotein Ib-IX complex: Identification of sulfated residues and effect on ligand binding. Biochemistry 1994; 33:13946-13953.
24. Wyler B, Bienz D, Clemetson KJ, Luscher EF. Glycoprotein Ibα is the only phosphorylated major membrane glycoprotein in human platelets. Biochem J 1986; 234:373-379.
25. Vu T-KH, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991; 64:1057-1068.
26. 2+ mobilization. FEBS Lett 1991; 288:123-128.
27. Brass LF, Vassallo RR, Jr., Belmonte E, Ahuja M, Cichowski K, Hoxie JA. Structure and function of the human platelet thrombin receptor. J Biol Chem 1992; 267:13795-13798.
28. Lau L-F, Pumiglia K, Cote YP, Feinstein MB. Thrombin-receptor agonist peptides, in contrast to thrombin itself, are not full agonists for activation and signal transduction in human platelets in the absence of platelet-derived secondary mediators. Biochem J 1994; 303:391-400.
29. 2) by thrombin and thrombin receptor agonist peptide in human platelets. J Biol Chem 1995; 270:14816-14823.
30. Goodwin CA, Wheeler-Jones CPD, Kakkar VV, Deadman JJ, Authi KS, Scully MF. Thrombin receptor activating peptide does not stimulate platelet procoagulant activity. Biochem Biophys Res Commun 1994; 202:321-327.
31. Sugama Y, Tiruppathi CM, Janakidevi K, Andersen TT, Fenton II, J.W., Main AB. Thrombin-induced expression of endothelial P-Selectin and intercellular adhesion molecule-1: A mechanism for stabilizing neutrophil adhesion. J Cell Biol 1992; 119: 935-944.
32. Lum H, Andersen TT, Siflinger-Birnboim A, et al. Thrombin receptor peptide inhibits thrombin-induced increase in endothelial permeability by receptor desensitization. J Cell Biol 1993; 120:1491-1499.
33. mapkk) in fibroblasts. J Cell Biol 1993; 122:1079-1088.
34. mapk (ERK1) by α-thrombin and thrombin-receptor peptide agonist. Biochem J 1993; 289:209-214.
35. Jenkins AL, Bootman MD, Derridge MJ, Stone SR. Differences in intracellular calcium signaling after activation of the thrombin receptor by thrombin and agonist peptide in osteoblast-like cells. J Biol Chem 1994; 269:17104-17110.
36. Connolly AJ, Ishihara H, Kahn ML, Farese Jr, R. V., Coughlin SR. Role of the thrombin receptor in development and evidence for a second receptor. Nature 1996; 381:516-519.
37. Darrow AL, Fung-Leung W-P, Ye RD, et al. Biological consequences of thrombin receptor deficiency in mice. Thromb Haemost 1996; 76:860-866.
38. Seiler SM, Michel IM, Fenton JW. Involvement of the "tethered-ligand" receptor in thrombin inhibition of platelet adenylate cyclase. Biochem Biophys Res Commun 1992; 182:1296-1302.
39. Baffy G, Yang L, Raj S, Manning DR, Williamson JR. G protein coupling to the thrombin receptor in chinese hamster lung fibroblasts. J Biol Chem 1994; 269:8483-8487.
40. 2 (14-3-3 protein) with the platelet glycoprotein Ib-IX complex. J Biol Chem 1994; 269:18287-18290.
41. Ishii K, Chen J, Koch WJ, Freedman NJ, Lefkowitz RJ, Coughlin SR. Inhibition of thrombin receptor signaling by a G-protein coupled receptor kinase. J Biol Chem 1994; 269:1125-1130.
42. Hung DT, Vu T-KH, Nelken NA, Coughlin SR. Cloned platelet thrombin receptor is necessary for thrombin-induced platelet activation. J Clin Invest 1992; 89:1350-1353.
43. Ishii K, Hein L, Kobilka B, Coughlin SR. Kinetics of thrombin receptor cleavage on intact cells. J Biol Chem 1993; 268:9780-9786.
44. Shuman MA, Levine SP. Thrombin generation and secretion of platelet factor 4 during blood clotting. J Clin Invest 1978; 61:1102-1106.
45. Wewer UM, Liotta LA, Jaye M, et al. Altered levels of laminin receptor mRNA in various human carcinoma cells that have different abilities to binding laminin. Proc Natl Acad Sci USA 1986; 83:7137-7141.
46. Smalheiser NR, Schwartz NB. Cranin: A laminin-binding protein of cell membranes. Proc Natl Acad Sci USA 1987; 84:6457-6461.
47. Terranova VP, Rao CN, Kalebic T, Margulies IM, Liotta LA. Laminin receptor on human breast carcinoma cells. Proc Natl Acad Sci USA 1983; 80:444-448.
48. Liu L, Freedman J, Hornstein A, Fenton JW, II, Song Y, Ofosu FA. Binding of thrombin to the G-protein-linked receptor, and not to glycoprotein Ib, precedes thrombin-mediated platelet activation. J Biol Chem 1997; 272:1997-2004.
49. From an address at the inauguration of the Faculty of Science of the University of Lille, 7 December 1854; in R. Vallery-Radot La Vie de Pasteur (1900) Ch. 4.